Skip to main content

Miromatrix moves into new headquarters, adding production capacity for bioengineered organs

The new space gives the company room to manufacture organs for pre-clinical and clinical trials.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.